Valuation SMAIO

Stocks

Market Closed - Euronext Paris 11:55:00 2026-08-21 EDT			5-day change	1st Jan Change
7.760 ^EUR	+2.11%		+1.57%	+24.16%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16.99	16.1	13.46	35.24	42.81	-	-
Change	-	-5.23%	-16.43%	161.89%	21.46%	-	-
Enterprise Value (EV) ¹	11.95	12.4	12.54	34.26	41.31	41.91	42.61
Change	-	3.81%	1.07%	173.25%	20.58%	1.45%	1.67%
P/E	-	15.2x	-5.73x	-15.2x	-19.9x	194x	36.1x
PBR	-	-	-	-	7.05x	7.05x	5.97x
PEG	-	-	0x	1.71x	4.08x	-2x	0x
Capitalization / Revenue	7.08x	2.99x	2.45x	3.83x	3.89x	2.68x	2.05x
EV / Revenue	4.98x	2.3x	2.28x	3.72x	3.76x	2.62x	2.04x
EV / EBITDA	-4.7x	6.02x	-7.16x	-28.1x	-37.6x	28.9x	16.7x
EV / EBIT	-2.99x	16.8x	-3.94x	-13x	-15.9x	-279x	53.3x
EV / FCF	2.34x	-9.16x	-4.19x	-26.5x	-15x	-33.5x	-426x
FCF Yield	42.7%	-10.9%	-23.8%	-3.78%	-6.66%	-2.98%	-0.23%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-	0.2024	-0.45	-0.41	-0.39	0.04	0.215
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	2.4	5.383	5.498	9.2	11	16	20.9
EBITDA ¹	-2.544	2.059	-1.751	-1.22	-1.1	1.45	2.55
EBIT ¹	-4	0.7368	-3.184	-2.628	-2.6	-0.15	0.8
Net income ¹	2.846	1.058	-2.349	-2.229	-2.25	0.25	1.2
Net Debt ¹	-5.044	-3.7	-0.921	-0.9873	-1.5	-0.9	-0.2
Reference price ²	3.250	3.080	2.580	6.250	7.760	7.760	7.760
Nbr of stocks (in thousands)	5,229	5,229	5,216	5,639	5,633	-	-
Announcement Date	4/11/23	4/29/24	4/24/25	4/27/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SMAIO	-19.49x	3.76x	-37.55x	-	50M
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,109B
JOHNSON & JOHNSON	29.74x	-	-	2.01%	644B
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	463B
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	371B
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	301B
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	256B
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	234B
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	205B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	14.06x	6.40x	10.10x	2.34%	376.11B
Weighted average by Cap.	25.34x	8.43x	18.53x	1.91%